These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3063125)

  • 1. [National inquiry on the outcome of severe head injuries: analysis of 921 injured patients treated with CDP-choline].
    Raggueneau JL; Jarrige B
    Agressologie; 1988 May; 29(6):439-43. PubMed ID: 3063125
    [No Abstract]   [Full Text] [Related]  

  • 2. CDP-choline: pharmacological and clinical review.
    Secades JJ; Frontera G
    Methods Find Exp Clin Pharmacol; 1995 Oct; 17 Suppl B():1-54. PubMed ID: 8709678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A precursor of phospholipids in the treatment of severe traumatic comas].
    Cohadon F; Richer E; Poletto B
    Neurochirurgie; 1982; 28(4):287-90. PubMed ID: 6759958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDP-choline as a drug for pancreatitis.
    Hashihira S; Nishii T; Mori R; Takeda Y; Tai J
    Bull Osaka Med Sch; 1974 Jul; 20(1):19-25. PubMed ID: 4457204
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical flow sonographic and telethermographic evaluation of arteriopathy patients treated with CDP-choline].
    Setti M; Ambrosi R; Nespoli M; Terraneo F; Briolini F; Losapio GM
    Minerva Cardioangiol; 1985 Dec; 33(12):859-62. PubMed ID: 3912681
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of chronic dyskinesia with CDP-choline.
    Arranz J; Ganoza C
    Arzneimittelforschung; 1983; 33(7A):1071-3. PubMed ID: 6684469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral CDP-choline on experimental withdrawal syndrome.
    Tornos ME; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1018-21. PubMed ID: 6684454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CDP choline and cerebrovascular insufficiency in the elderly. Clinical study of 40 patients undergoing prolonged treatment].
    Merchan C; Berchicci R; Cuzzoni G; Pecorini M
    Minerva Cardioangiol; 1985 Mar; 33(3):145-8. PubMed ID: 4010981
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of the effect of CDP in patients with motor disorders of cerebral origin].
    Asirón Yribarren PJ; Bascuas Asta JL; Marín Górriz F; Marín Redondo J; Noguera Lobera AR; Ramos Cristóbal JA
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1978; 6(1):97-104. PubMed ID: 654990
    [No Abstract]   [Full Text] [Related]  

  • 10. [CDP choline and experimental cerebrovascular disorder].
    Le Poncin-Lafitte M; Duterte D; Lageron A; Rapin JR
    Agressologie; 1986 May; 27(5):413-6. PubMed ID: 3766895
    [No Abstract]   [Full Text] [Related]  

  • 11. [Alveolar surfactant and experimental diabetes (protective action of citicoline)].
    Iozzo A; Cardellino G; Dalmasso F; Garbagni R
    Arch Sci Med (Torino); 1978; 135(2):181-6. PubMed ID: 581158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Controlled study of the administration of CDP-choline to preterm newborn infants with respiratory distress syndrome].
    Valls i Soler A; Sanjurjo P; Vázquez Cordero C
    An Esp Pediatr; 1988 Jun; 28(6):493-6. PubMed ID: 3195851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CDP choline in cerebral vasculopathy: clinical evaluation and instrumental semeiology].
    Corso EA; Arena M; Ventimiglia A; Bizzarro G; Campo G; Rodolico F
    Clin Ter; 1982 Aug; 102(4):379-86. PubMed ID: 6754218
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic effects of CDP-choline and premarin in acute experimental pancreatitis].
    Yamada N; Nakamura K; Zeze F; Ishii K
    Nihon Rinsho; 1976 Aug; 34(8):1758-61. PubMed ID: 185437
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological study of CDP-choline. Protection against toxicity in a model of experimental hypoxia.
    Tornos ME; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1022-4. PubMed ID: 6684455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CDP choline and glucose metabolism. Study of clinical pharmacology].
    Angeli G; Moretti GB; Paris B; Bertone V
    Minerva Dietol Gastroenterol; 1985; 31(1):15-20. PubMed ID: 3889717
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diurnal variation of serum cortisol and CDP-choline treatment of patients in the vegetative state].
    Saito Y; Kitane Y; Kawaguchi N; Nojima T; Takahashi
    Horumon To Rinsho; 1975 Oct; 23(10):1021-8. PubMed ID: 1238182
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of oral CDP-choline. Drug surveillance study in 2817 cases.
    Lozano Fernández R
    Arzneimittelforschung; 1983; 33(7A):1073-80. PubMed ID: 6684470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxotremorine-induced cholinergic syndrome: modifications by levodopa and/or oral cytidine diphosphocholine.
    Saligaut C; Daoust M; Chadelaud M; Moore N; Chretien P; Boismare F
    Methods Find Exp Clin Pharmacol; 1985 Jan; 7(1):5-8. PubMed ID: 3990445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissimilar effects in acute toxicity studies of CDP-choline and choline.
    Agut J; Font E; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1016-8. PubMed ID: 6684453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.